Overview
A clinical research fellowship in multiple myeloma and mature B-cell lymphoproliferative disorders, including intensive therapy, autologous stem cell transplantation and novel-agent drug development.
The programme
- Training type
- Clinical Fellowship
- Duration
- 2 years
- Start
- 1 July
- Positions
- Not stated on official page
- Accreditation
- University of Toronto Department of Medicine clinical fellowship registered with PGME; does not lead to RCPSC certification (UofT PGME page)
- Department
- Department of Medicine, Division of Hematology
Eligibility and visa
- Eligibility
- Completed subspecialty training in internal medicine and/or medical oncology or hematology; eligible for CPSO licensure
- International applicants
- Non-Canadian applicants who meet CPSO clinical-fellow licensure requirements contact the Fellowship Program Director; citizens of Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and UAE must apply through their sponsoring agency to the PGME Office (UofT PGME page)
- Visa support
- PGME Office provides successful sponsored applicants with documentation to apply for a work permit (UofT PGME page); otherwise not stated on official page
- Licence requirement
- Must be eligible for a CPSO certificate authorizing postgraduate education (educational licence); applicant must be recognized as a specialist in the jurisdiction where they practised (UofT PGME page)
How to apply
- Deadline
- Not stated on official page
- Application method
- Contact Claudia Scheckmann, UHN Medical Oncology & Hematology Fellowship Administrator (claudia.scheckmann@uhn.ca)
Funding
- Funding
- Not stated on official page